MiNK Therapeutics (INKT) Q4 2023 Earnings

21MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.24
-0.16
-0.08
0

Details

Expected EPS
-0.15
Actual EPS
-0.16
Surprise EPS
-0.01
Surprise Percent
+6.67%

Description

MiNK Therapeutics (INKT) has reported earnings of -0.16 per share for Q4 2023.

0 Comments

Share your thoughts